Trials / Completed
CompletedNCT05673239
Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients
Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients: A Multicenter, Prospective, Non-randomized, Controlled Real-world Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,008 (actual)
- Sponsor
- The First Affiliated Hospital of Zhejiang Chinese Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to be a multicenter, prospective, non-randomized, controlled real-world study. Patients receiving L-carnitine injection were included in the experimental group and the control group according to whether they received L-carnitine injection. Patients receiving L-carnitine injection were included in the experimental group, and those receiving L-carnitine injection were included in the control group.To observe the effects of L-carnitine on cardiac function in hemodialysis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocarnitine Injection | The patients in the test group were injected with 1-2g (10-20mg/kg) levocarnitine on each dialysis day |
Timeline
- Start date
- 2023-01-15
- Primary completion
- 2023-06-30
- Completion
- 2024-06-30
- First posted
- 2023-01-06
- Last updated
- 2024-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05673239. Inclusion in this directory is not an endorsement.